Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on May 14, 2025
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
GlobeNewswire
·
May 14, 2025
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant fluid overload in …
Best Creatine For Men 2025: Top Athlete-Tested Supplements for Muscle Growth, Strength & Recovery
GlobeNewswire
·
May 14, 2025
Glasgow, May 14, 2025 (GLOBE NEWSWIRE) -- Introduction In simple words, creatine is a substance that occurs naturally in our muscle cells. It helps our muscles produce enough energy while we perform intense activities such as heavyweight lifting or a high …
Sevaro Launches Nationwide Stroke Awareness Campaign With Racecars, Storybooks, and Student Heroes
GlobeNewswire
·
May 14, 2025
CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- A stroke happens every 40 seconds in the U.S.—and every minute without treatment can cost a person 1.9 million brain cells. This May, during Stroke Awareness Month Sevaro Health is shifting the narrative— …
The Best Steroids for Cutting, Muscle Growth & Strength for Weight Training - Top Legal Steroid Stacks for Bulking, Fat Loss, Getting Shredded & Ripped - CrazyBulk
GlobeNewswire
·
May 14, 2025
New York City, NY, May 14, 2025 (GLOBE NEWSWIRE) -- For serious bodybuilders and weightlifters, achieving fast muscle growth and that shredded look takes more than just hard work in the gym. The right steroid stack will push past limits, pack on lean …
REPEAT/Media Advisory/OHC - Day of Action at Ontario Legislature to Stop Hospital Closures
GlobeNewswire
·
May 14, 2025
TORONTO, May 14, 2025 (GLOBE NEWSWIRE) -- On Wednesday May 14, people from across Ontario will be heading into the Ontario Legislature for a “Day of Action” to ask the Ford government to stop closing their local hospitals and to provide the resources …
Angelini Ventures Invests into $39 Million Series A Extension Round for Therini Bio, a Clinical Stage Company Developing Fibrin-targeting Immunotherapies for Neurodegenerative Diseases
GlobeNewswire
·
May 14, 2025
Angelini Ventures joins top-tier investor syndicate Investment will fund Phase 1b studies evaluating Therini Bio’s lead candidate, THN391, for the treatment of Alzheimer’s Disease (AD) and Diabetic Macular Edema (DME), as well as support development of a …
“Say the ‘S’ word:” Physician-Patient Alliance for Health & Safety Launches CME Sepsis Courses
GlobeNewswire
·
May 14, 2025
Chicago, IL, May 14, 2025 (GLOBE NEWSWIRE) -- “Say the ‘S’ word:” Physician-Patient Alliance for Health …
Kura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) Congress
GlobeNewswire
·
May 14, 2025
– Ziftomenib combined with 7+3 in 1L NPM1-m or KMT2A-r AML patients selected for oral presentation on Thursday, June 12th – – Updated dataset to be presented in oral presentation at EHA2025 Congress – SAN DIEGO and TOKYO, May 14, 2025 (GLOBE NEWSWIRE) -- …
Therini Bio Raises Additional $39M Series A Financing to Advance Clinical Development of Neurodegenerative Disease Pipeline
GlobeNewswire
·
May 14, 2025
- Angelini Ventures and Apollo Health Ventures join existing top-tier investor syndicate - Follows original $36M Series A raise and brings Series A total to $75M - Proceeds are being used to fund Phase 1b Alzheimer’s and DME studies, and bispecific …
Agios to Highlight Pyruvate Kinase Activation Portfolio with New Data in Rare Blood Disorders at 30th EHA Congress
GlobeNewswire
·
May 14, 2025
CAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s PK …
Editas Medicine to Present in vivo HSC Delivery, Editing, and Biodistribution Data at the European Hematology Association 2025 Congress in June
GlobeNewswire
·
May 14, 2025
Preclinical studies achieved therapeutically relevant gene editing levels of the HBG1/2 promoter …
Nurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant Lymphoma
GlobeNewswire
·
May 14, 2025
SAN FRANCISCO, May 14, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that …
Beam Therapeutics to Highlight New Data from BEAM-101 Program in Sickle Cell Disease at European Hematology Association (EHA) 2025 Congress
GlobeNewswire
·
May 14, 2025
Presentation to Include Updated Data from 17 Sickle Cell Disease Patients in the Ongoing BEACON Phase 1/2 Clinical Trial Evaluating Safety and Efficacy of BEAM-101 Beam to Host Investor Webcast on Friday, June 13, 2025, at 4:00 p.m. ET CAMBRIDGE, Mass., …
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2025 Congress
GlobeNewswire
·
May 14, 2025
Poster presentations across all programs, including data from HELIOS long-term extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of DISC-0974 in anemia of myelofibrosis (MF), and additional …
Co-Diagnostics, Inc. to Participate in D. Boral Inaugural Global Conference
GlobeNewswire
·
May 14, 2025
Salt Lake City, Utah, May 14, 2025 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company” or “Co-Dx”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that …
Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
GlobeNewswire
·
May 14, 2025
LONDON, May 14, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces the online publication of …
Syndax Announces Data Presentations at EHA 2025 Showcasing Revuforj® (revumenib) and Niktimvo™ (axatilimab-csfr)
GlobeNewswire
·
May 14, 2025
– Revumenib abstracts highlight compelling results in acute leukemia across the frontline and R/R setting and multiple genetic populations, including mNPM1, KMT2Ar, and NUP98r – – Axatilimab abstracts highlight the robust responses observed in different …
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701
GlobeNewswire
·
May 14, 2025
Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including difficult-to-treat resistance mutations Early dose-escalation data from Phase 1 CARDINAL study of TERN-701 in CML patients showed …
Autonomix CEO Brad Hauser to Present at Virtual Investor’s Closing Bell Event
GlobeNewswire
·
May 14, 2025
Live webcast followed by an interactive Q…
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call
GlobeNewswire
·
May 14, 2025
LITTLETON, Colo., May 14, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary …